Skip to content
Thursday, November 12, 2026
British Classic Insight

Zimbabwe Turns Down ‘Unbalanced’ US Health Aid Deal Over Information Fears

Medical funding illustration
The proposed American funding would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has rejected a substantial US health deal valued at $367m (£272m) spanning five years over Washington's demand for sensitive data.

The decision became public after a official document from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".

A government spokesman has since clarified that the US was demanding access to biological samples for research and commercial gain while was unwilling to guarantee the resulting advantages from any future medical innovations.

"We will now turn to the challenging and unfortunate process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy said the United States had donated more than $1.9bn in health funding to Zimbabwe over the last twenty years.

A medical body in Zimbabwe has appealed for more negotiations to secure a deal acceptable to all parties so the country's critical HIV treatment initiative can be sustained.

Wider Context

Zimbabwe's decision comes after a comparable situation in Kenya, where a court halted a related health funding agreement following legal challenges were filed about the security of citizens' health data.

After returning to office last year, US President Donald Trump has slashed foreign aid and shut down the US Agency for International Development (USAID).

USAID had managed aid for the American government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to enhance transparency and responsibility.

As per reports, Sixteen African countries have so far signed similar agreements, constituting more than $18.3bn in committed funds.

Details of the Declined Agreement

This assistance for Zimbabwe would have funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration might have yielded extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently receiving antiretroviral therapy via US-supported programmes," the Ambassador commented.

However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".

"The proposal required Zimbabwe to share its genetic material and health information for a long time, without any corresponding promise of benefiting from any medical innovations – such as new medicines or tests – that might result from that shared data," his statement read.

"In essence, our nation would provide the raw materials for medical research with no certainty that the end products would be available to our population if a new pandemic arise."

Sovereignty and International Frameworks

Mangwana further noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were undermining structures already established via the global organization.

The spokesperson cited its Pathogen Access and Benefit Sharing framework created to deal with potential pandemics.

"This system is intended to guarantee that when a country contributes its information, the benefits – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to develop them."

These objections regarding the US deal "are not meant as opposition to America," he added.

"We are open to further dialogue with our American counterparts on how future co-operation could be arranged in a way that honours the sovereignty and interests of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but suggested that negotiations need to persist considering much of the country's HIV programmes relied on international support.

"Where specific concerns arise, including those involving data governance or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," the group added.

The halted deal highlights the complex challenges between receiving much-needed international aid and protecting a country's data in an ever more interconnected world.

NC
The writer

Nicole Cohen

A historian and writer with a passion for British heritage, Eleanor explores the stories behind classic designs and cultural icons.

British Classic Insight

Type to search articles.